Back to Team Previously with: Milena Kanova Head of Quality Milena has over 25 years of experience in clinical research, people, and team management delivering portfolios across multiple therapeutic indications in all stages of drug development as a strategic...
Back to Team David Simmons Chairman of the Board, Launch Tx David joined Caliber Collision (Hellman & Friedman is majority owner) in 2023 as Chief Executive Officer. While being in a different industry than life sciences, the business has similar structural...
Back to Team William Sharbaugh Former President & COO, PPD Bill Sharbaugh has over 30 years of experience in the pharmaceutical industry. Most recently, Bill served as Chief Operating Officer of PPD for 15 years. Prior to joining PPD, he held various roles at...
Back to Team Ian Read Former Chairman & CEO, Pfizer During Mr. Read’s tenure as CEO, Pfizer generated a total shareholder return of 250%, achieved 32 FDA approvals for new medicines, invested significantly in research and development, and completed several...
Back to Team Laura Hamill Former EVP, Worldwide Commercial Operations, Gilead Laura J. Hamill has deep experience in the biopharmaceutical industry, with over 30 years of global commercial experience in a variety of executive leadership positions. Most recently, she...
